Courtney A McKnight

Scroll

Clinical Assistant Professor of Epidemiology

Dr. Courtney McKnight is a Principal Investigator specializing in mixed methods research focused on the epidemiology of drug use, opioid overdose, HIV and HCV infection. Dr. McKnight has over 20 years of experience conducting public health research related to drug use, as well as field experience as a harm reduction service provider.

Prior to joining NYU, Dr. McKnight served as the assistant director of research at the Chemical Dependency Institute at the Icahn School of Medicine at Mount Sinai, where she was an investigator and project director on numerous federally funded research studies, including evaluations of syringe services programs; investigations of the drivers that contribute to disparate rates of HIV and HCV; and interventions to increase access to HIV and HCV testing and care.

Previous to Dr. McKnight’s work in research, she directed a harm reduction program for women who use drugs and volunteered at a syringe services program in New Jersey.

Dr. McKnight received her DrPH from the City University of New York Graduate Center, her Master of Public Health from Hunter College, and her Bachelor of Arts in sociology from Rutgers University. Her dissertation examined the impact of Medicaid coverage of methadone and buprenorphine on treatment access for opioid dependent beneficiaries.

Dr. McKnight’s current research interests include examining the shifting landscape of illicit opioids, including the increasing prevalence of illicitly manufactured fentanyl, and risk environments of people who use drugs.

Education

BA, Women's Studies, Rutgers University, New Brunswick, NJ

MPH, Community Health Education, Hunter College, New York, NY

DrPH, The City University of New York, New York, NY

Areas of research and study

Behavioral Science

Drug addiction

Epidemiology

Harm reduction

Hepatitis

HIV/AIDS

Infectious Diseases

Mixed-Methods Research

Opioid

Qualitative Research

Social epidemiology

Substance Abuse

Publications

Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000–2017: Protective effects of non-injecting drug use

Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001–2005 and 2011–2015

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York city, 2011-2015, with implications for the current opioid epidemic in the US

Decline in herpes simplex virus type 2 among non-injecting heroin and cocaine users in New York City, 2005 to 2014: Prospects for avoiding a resurgence of human immunodeficiency virus

Decline in HSV-2 among non-injecting Heroin and Cocaine users in New York City, 2005-2014: potential protection against HIV resurgence

Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization

Racial/ethnic disparities at the end of an HIV epidemic: Persons who inject drugs in New York City, 2011-2015

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention

The New York 911 Good Samaritan Law and Opioid Overdose Prevention Among People Who Inject Drugs

What happened to the HIV epidemic among non-injecting drug users in New York City?

Consistent estimates of very low HIV incidence among people who inject drugs: New York City, 2005-2014

From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits

Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for “Ending the Epidemic”

Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013

Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance

Will "combined prevention" eliminate racial/ethnic disparities in HIV infection among persons who inject drugs in New York City?

A perfect storm: Crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City

Combined HIV prevention, the New York City Condom Distribution Program, and the evolution of safer sex behavior among persons who inject drugs in New York City